NCT04757792

Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 475 (actual)
• Sponsor: Benha University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Retrospective multicenter study to evaluate the data of COVID-19 patients who were admitted to university hospitals in relation to their recent administration or maintenance on non-steroidal anti-inflammatory drugs (NSAID) prior to have COVID-19 disease and to analyze it in relation to outcome of these patients.

Detailed description

The data contained in hospital registry were collected, categorized into demographic, previous medical history, the use of NSAID as maintenance therapy or its recent administration before diagnosis of COVID-19 disease, presenting manifestations, laboratory and CT findings, applied therapies or interventions. Outcomes will be categorized as survival and non-survival outcome. Survivors will be subdivided as complete recovery or recovery with getting new morbidities. Mortality was subdivided as total hospital and ICU mortality. Data will be statistically analyzed in relation to outcomes

Conditions

• COVID-19 Disease

Interventions

Type	Name	Description
OTHER	File inquiry	Data extraction out of file registry

Timeline

• Start date: 2020-06-06
• Primary completion: 2021-02-01
• Completion: 2021-02-11
• First posted: 2021-02-17
• Last updated: 2021-02-17

Locations

1 site across 1 country: Egypt